"Shkreli told Xconomy earlier this year that he felt he could make more of a difference to the world of life sciences by actually developing drugs himself, which is what inspired him to start Retrophin. He is being advised by some of the pharmaceutical industry’s best-known executives, including Fred Hassan, the former Schering-Plough CEO, and Brent Saunders, CEO of Bausch & Lomb. In terms of funding the company going forward, Shkreli says he would consider merging with a public company that already has a strong drug-development engine."

In other words...I'm only doing this to help mankind(one m) but I'm ready to sell this company tomorrow if I can make enough money.